Branded Drug Makers Face Increasingly Aggressive Challenges By Generic Makers, Study Finds
Makers of branded drugs are increasingly turning to patent litigation to defend their blockbuster drugs, a new survey has found....To view the full article, register now.
Already a subscriber? Click here to view full article